Clinical Drug Development

Course Overview

Offered by Queen Mary University of London, the MSc Clinical Drug Development provides a comprehensive postgraduate education in medicine and dentistry. Based in Islington, England, this Russell Group university offers a research-led approach to learning, with a 1-year full-time and part-time structure. The MSc in Clinical Drug Development provides students with a multidisciplinary perspective to facilitate their skills. The programme is designed for individuals who need an understanding of drug development process and provides a detailed picture of the complex and highly interrelated activities required for the development cycle for drugs and biologics, from the process of discovery to successful commercialisation. - This programme provides students with the edge that the pharmaceutical industry requires. International tuition fees are £8,850 per year, home/UK fees are £22,000 per year, and a minimum IELTS score of 6.5 is required for admission. Graduates from this programme benefit from strong career prospects, with a median graduate salary of £46,500 within three years, and 75% of graduates in employment or further study.

What You'll Learn

Tuition Fees & Funding

Fees shown are for current entry. Fees may increase annually in line with inflation.

Graduate Outcomes

Frequently Asked Questions